Search

Search Constraints

You searched for: Author/Creator Weinstein, Arthur

Search Results

1. 237 Cell bound complement activation products in combination with low complement C3 or C4 have high diagnostic yield in systemic lupus erythematosus. (April 2019)

3. A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus. Issue 1 (12th July 2021)

4. A Multianalyte Assay Panel With Cell‐Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology–Classified Lupus. Issue 2 (4th February 2021)

5. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)

6. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)

7. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)

8. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)

9. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)

10. Cell-bound complement activation products associate with lupus severity in SLE. Issue 1 (5th May 2020)